Sjögren's syndrome: a systemic autoimmune disease
S Negrini, G Emmi, M Greco, M Borro… - Clinical and …, 2022 - Springer
Sjögren's syndrome is a chronic autoimmune disease characterized by ocular and oral
dryness resulting from lacrimal and salivary gland dysfunction. Besides, a variety of systemic …
dryness resulting from lacrimal and salivary gland dysfunction. Besides, a variety of systemic …
Pathogenesis and treatment of Sjogren's syndrome: review and update
Q Zhan, J Zhang, Y Lin, W Chen, X Fan… - Frontiers in …, 2023 - frontiersin.org
Sjogren's syndrome (SS) is a chronic autoimmune disease accompanied by multiple
lesions. The main manifestations include dryness of the mouth and eyes, along with …
lesions. The main manifestations include dryness of the mouth and eyes, along with …
[HTML][HTML] The diagnosis and treatment of Sjögren's syndrome
AL Stefanski, C Tomiak, U Pleyer… - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background Sjögren's syndrome is one of the more common inflammatory rheumatological
diseases, with a prevalence of at least 0.4% in Germany. Methods This review is based on …
diseases, with a prevalence of at least 0.4% in Germany. Methods This review is based on …
[HTML][HTML] A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome
X Mariette, F Barone, C Baldini, H Bootsma, KL Clark… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Primary Sjögren's syndrome (pSS) is characterized by B cell hyperactivity
and elevated B-lymphocyte stimulator (BLyS). Anti-BLyS treatment (eg, belimumab) …
and elevated B-lymphocyte stimulator (BLyS). Anti-BLyS treatment (eg, belimumab) …
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
R Felten, V Devauchelle-Pensec, R Seror… - Annals of the …, 2021 - ard.bmj.com
Objectives No immunomodulatory drug has been approved for primary Sjögren's syndrome,
a systemic autoimmune disease affecting 0.1% of the population. To demonstrate the …
a systemic autoimmune disease affecting 0.1% of the population. To demonstrate the …
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial
AN Baer, JE Gottenberg, EW St Clair… - Annals of the …, 2021 - ard.bmj.com
Objectives To evaluate efficacy and safety of abatacept in adults with active primary
Sjögren's syndrome (pSS) in a phase III, randomised, double-blind, placebo-controlled trial …
Sjögren's syndrome (pSS) in a phase III, randomised, double-blind, placebo-controlled trial …
Microbiota dysbiosis in primary Sjögren's syndrome and the ameliorative effect of hydroxychloroquine
The human microbiome plays an important role in autoimmune diseases. However, there is
limited knowledge regarding the microbiota in individuals with primary Sjögren's syndrome …
limited knowledge regarding the microbiota in individuals with primary Sjögren's syndrome …
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of …
Summary Background Primary Sjögren's syndrome is an autoimmune disease that presents
as dryness of the mouth and eyes due to impairment of the exocrine glands. To our …
as dryness of the mouth and eyes due to impairment of the exocrine glands. To our …
Sjögren's syndrome: more than just dry eye
EK Akpek, VY Bunya, IJ Saldanha - Cornea, 2019 - journals.lww.com
Purpose: Sjögren's syndrome (SS) is a common autoimmune disease affecting about four
million Americans. Although approximately 1 in 10 patients with clinically-significant …
million Americans. Although approximately 1 in 10 patients with clinically-significant …
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations
P Brito-Zerón, E Theander, C Baldini… - Expert review of …, 2016 - Taylor & Francis
Sjögren's syndrome (SjS) is a systemic autoimmune disease that mainly affects the exocrine
glands, leading to generalized mucosal dryness. However, primary SjS may initially present …
glands, leading to generalized mucosal dryness. However, primary SjS may initially present …